[go: up one dir, main page]

FI20070574A0 - Water-soluble ethylene phosphate prodrug of propofol - Google Patents

Water-soluble ethylene phosphate prodrug of propofol

Info

Publication number
FI20070574A0
FI20070574A0 FI20070574A FI20070574A FI20070574A0 FI 20070574 A0 FI20070574 A0 FI 20070574A0 FI 20070574 A FI20070574 A FI 20070574A FI 20070574 A FI20070574 A FI 20070574A FI 20070574 A0 FI20070574 A0 FI 20070574A0
Authority
FI
Finland
Prior art keywords
propofol
water
phosphate prodrug
soluble ethylene
ethylene phosphate
Prior art date
Application number
FI20070574A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Hanna Kumpulainen
Tomi Jaervinen
Jarkko Rautio
Original Assignee
Kuopion Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuopion Yliopisto filed Critical Kuopion Yliopisto
Priority to FI20070574A priority Critical patent/FI20070574A0/en
Publication of FI20070574A0 publication Critical patent/FI20070574A0/en
Priority to PCT/FI2008/050446 priority patent/WO2009016269A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20070574A 2007-07-30 2007-07-30 Water-soluble ethylene phosphate prodrug of propofol FI20070574A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20070574A FI20070574A0 (en) 2007-07-30 2007-07-30 Water-soluble ethylene phosphate prodrug of propofol
PCT/FI2008/050446 WO2009016269A1 (en) 2007-07-30 2008-07-30 Water-soluble ethylidene phosphate prodrug of propofol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20070574A FI20070574A0 (en) 2007-07-30 2007-07-30 Water-soluble ethylene phosphate prodrug of propofol

Publications (1)

Publication Number Publication Date
FI20070574A0 true FI20070574A0 (en) 2007-07-30

Family

ID=38331586

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20070574A FI20070574A0 (en) 2007-07-30 2007-07-30 Water-soluble ethylene phosphate prodrug of propofol

Country Status (2)

Country Link
FI (1) FI20070574A0 (en)
WO (1) WO2009016269A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9150600B2 (en) 2009-05-07 2015-10-06 Regents Of The University Of Minnesota Triptolide prodrugs
DK2427467T3 (en) * 2009-05-07 2015-11-09 Univ Minnesota Triptolid prodrugs
CN102784099A (en) * 2012-06-11 2012-11-21 陕西合成药业有限公司 Combined preparation containing fospropofol disodium, and preparation method and application thereof
CN103588810B (en) * 2013-11-29 2016-03-30 成都理工大学 Propofol water-soluble naphthenic phosphate ester derivative
WO2017205632A1 (en) * 2016-05-27 2017-11-30 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol
US11628178B2 (en) 2019-03-26 2023-04-18 Epalex Corporation Fospropofol methods and compositions
US11547714B2 (en) 2020-02-05 2023-01-10 Epalex Corporation Fospropofol salts, methods and compositions
US11478490B1 (en) 2021-03-30 2022-10-25 Epalex Corporation Fospropofol formulations
US11439653B1 (en) 2021-03-30 2022-09-13 Epalex Corporation Fospropofol formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1056754T3 (en) * 1998-01-29 2004-02-16 Bristol Myers Squibb Co Phosphate derivatives of diaryl-1,3,4-oxadiazolone
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds
CA2571726C (en) * 2004-07-06 2013-05-21 Abbott Laboratories Prodrugs of hiv protease inhibitors

Also Published As

Publication number Publication date
WO2009016269A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
HUS1900029I1 (en) Kinase inhibitor phosphorus derivatives
FI20070574A0 (en) Water-soluble ethylene phosphate prodrug of propofol
PL2144618T3 (en) Bio-effective compositions from krill oil
DK2634231T3 (en) COMPOSITIONS
DK2285786T3 (en) Quinoxalinedione DERIVATIVES
ME01423B (en) FUNGICID COMPOSITIONS
DK2214679T3 (en) CORTICOSTEROID COMPOSITIONS
HUE056966T2 (en) Grooving procedure
DK3056214T3 (en) HOWEVER, UNKNOWN ADDITIONAL COMPOSITIONS
BRPI0922181A2 (en) anti-corrosive particles
EP2379510A4 (en) QUINAZOLINONE COMPOUNDS
EP2350385A4 (en) FORM FIELD
FI20085767A0 (en) Gypsum Product
UY31688A1 (en) PESTICIDES
DE112008002581A5 (en) powertrain
EP2318306A4 (en) NANO COMPOSITIONS
DE112007003038A5 (en) powertrain
DK2170292T3 (en) Tablet-containing Atazanavir Compositions
BRPI0921199A2 (en) tire balancing compositions
EP2600912A4 (en) SELF-EXTENDING BIOPOLYMER MINERAL COMPOUND
BRPI0922256A2 (en) nanoparticle compositions
BRPI0913967A2 (en) brake
BRPI0807533A2 (en) BRAKING
FR2915747B1 (en) TRI-AMINO-PYRIMIDINE DERIVATIVES AS CDC25 PHOSPHATASE INHIBITORS
FI20095056A0 (en) Procedure for the manufacture of firewood

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: FENNOPHARMA OY

Free format text: FENNOPHARMA OY